The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
IMmotion151: A Randomized Phase III Study of Atezolizumab Plus Bevacizumab vs Sunitinib in Untreated Metastatic Renal Cell Carcinoma (mRCC)
 
Robert J. Motzer
Consulting or Advisory Role - Eisai; Exelixis; Merck; Novartis; Pfizer
Research Funding - Bristol-Myers Squibb (Inst); Eisai (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Novartis (Inst); Pfizer (Inst)
 
Thomas Powles
Honoraria - Bristol-Myers Squibb; MERCK; Roche/Genentech
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Genentech/Roche; Merck; Novartis
Research Funding - AstraZeneca/MedImmune; Roche/Genentech
Other Relationship - Bristol-Myers Squibb; Ipsen
 
Michael B. Atkins
Honoraria - Bristol-Myers Squibb
Consulting or Advisory Role - Acceleron Pharma; Agenus; Alexion Pharmaceuticals; Argos Therapeutics; Array BioPharma; AstraZeneca/MedImmune; Bristol-Myers Squibb; Celldex; Eisai; Exelixis; Genentech; Genoptix; Glactone Pharma; Idera; Merck; Nektar; Novartis; Peleton; Pfizer; X4 Pharma
 
Bernard Escudier
Honoraria - Bristol-Myers Squibb; Eisai; EUSA Pharma; Ipsen; Novartis; Pfizer; Roche
Research Funding - AVEO (Inst); Bristol-Myers Squibb (Inst); Ipsen (Inst); Novartis (Inst); Pfizer (Inst)
 
David F. McDermott
Consulting or Advisory Role - Alexion Pharmaceuticals; Array BioPharma; Bristol-Myers Squibb; Eisai; exelixis; Genentech/Roche; Merck; Novartis; Pfizer; X4 Pharma
Research Funding - Prometheus (Inst)
 
Cristina Suarez
Consulting or Advisory Role - Bristol-Myers Squibb; Pfizer
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Pfizer
 
Sergio Bracarda
Honoraria - Astellas Medivation; Bristol-Myers Squibb; Janssen; Novartis; Pfizer; Roche
Consulting or Advisory Role - Astellas Medivation; Bristol-Myers Squibb; Ipsen; MSD; Novartis; Pfizer; Roche
Travel, Accommodations, Expenses - Astellas Medivation; Bristol-Myers Squibb; Ipsen; Roche
 
Walter Michael Stadler
Honoraria - AstraZeneca; Bristol-Myers Squibb; CVS Caremark; Sotio
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; CVS Caremark; Sotio
Research Funding - Active Biotech (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Dendreon (Inst); Exelixis (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Janssen (Inst); Johnson & Johnson (Inst); Medivation (Inst); Merck (Inst); Millennium (Inst); Novartis (Inst); Pfizer (Inst); Roche/Genentech
Other Relationship - American Cancer Society; UpToDate
 
Frede Donskov
Research Funding - Novartis/Pfizer (Inst)
Travel, Accommodations, Expenses - Exelis
 
Jae-Lyun Lee
Honoraria - Astellas Pharma; Novartis; Pfizer
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Eisai
Research Funding - Exelixis; Janssen; Novartis; Pfizer
 
Robert E. Hawkins
Employment - Cellular Therapeutics
Leadership - Cellular Therapeutics
Stock and Other Ownership Interests - Cellular Therapeutics
Honoraria - Bristol-Myers Squibb; GlaxoSmithKline; Ipsen; Novartis; pfizer
Patents, Royalties, Other Intellectual Property - Medical Research Council - Phage Antibody Patents
 
Alain Ravaud
Honoraria - Bristol-Myers Squibb; Novartis; Pfizer
Consulting or Advisory Role - Bristol-Myers Squibb; Ipsen; Novartis; Pfizer; Roche
Research Funding - Novartis (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Novartis; Pfizer
 
Boris Y. Alekseev
No Relationships to Disclose
 
Michael D. Staehler
Honoraria - Bayer; Bristol-Myers Squibb; Exelixis; Ipsen; Novartis; Pfizer; Roche
Consulting or Advisory Role - Bristol-Myers Squibb; Eisai; Exelixis; Ipsen; Novartis; Pfizer
Speakers' Bureau - Bristol-Myers Squibb; Eisai; Ipsen; Novartis; Pfizer
Research Funding - Bayer (Inst); Bristol-Myers Squibb (Inst); Exelixis (Inst); Novartis; Pfizer (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Eisai; Ipsen; Novartis; Pfizer
 
Motohide Uemura
No Relationships to Disclose
 
Francis Donaldson
Employment - Roche
 
Shi Li
Employment - Genentech
 
Mahrukh A. Huseni
Employment - Genentech
 
Christina Schiff
Employment - Genentech
Stock and Other Ownership Interests - Genentech/Roche
 
Brian I. Rini
Consulting or Advisory Role - Corvus Pharmaceuticals; Merck; Pfizer
Research Funding - Bristol-Myers Squibb (Inst); Merck (Inst); Pfizer (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Pfizer